These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 336545)

  • 1. Isolation and properties of complement-resistant strains of Escherichia coli K-12.
    Akiyama Y; Inoue K
    Infect Immun; 1977 Nov; 18(2):446-53. PubMed ID: 336545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-mediated killing of Salmonella typhimurium and Escherichia coli mutants which share a different content of major proteins.
    Galdiero F; Sommese L; Capasso C; Galdiero M; Tufano MA
    Microbiologica; 1991 Apr; 14(2):119-30. PubMed ID: 1857264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between bactericidal action of complement and fluidity of cellular membranes.
    Kato K; Bito Y
    Infect Immun; 1978 Jan; 19(1):12-7. PubMed ID: 342407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical studies on damages of Escherichia coli by the immune bactericidal reaction. I. Release and degradation of phospholipids from damaged bacteria.
    Inoue K; Takamizawa A; Yano K; Amano T
    Biken J; 1974 Dec; 17(4):127-34. PubMed ID: 4619009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane changes induced by exposure of Escherichia coli to human serum.
    Kroll HP; Bhakdi S; Taylor PW
    Infect Immun; 1983 Dec; 42(3):1055-66. PubMed ID: 6358036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical studies on damages of Escherichea coli by the immune bactericidal reaction. II. Release of phosphatidylethanolamine from a phospholipase A-deficient mutant of E. coli during the immune bactericidal reaction.
    Inoue K; Yano K; Amano T
    Biken J; 1974 Dec; 17(4):135-40. PubMed ID: 4619010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable insertion of C5b-9 complement complexes into the outer membrane of serum treated, susceptible Escherichia coli cells as a prerequisite for killing.
    Kroll HP; Voigt WH; Taylor PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):316-26. PubMed ID: 6397947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular composition of the outer membrane of Escherichia coli and the importance of protein-lipopolysaccharide interactions.
    Gmeiner J; Schlecht S
    Arch Microbiol; 1980 Sep; 127(2):81-6. PubMed ID: 7000027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative biochemistry of the cell envelopes of Photobacterium leiognathi and Escherichia coli.
    Scott GK; Smith K; Thoreau CM
    J Gen Microbiol; 1983 May; 129(5):1583-7. PubMed ID: 6352861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.
    Pramoonjago P; Kaneko M; Kinoshita T; Ohtsubo E; Takeda J; Hong KS; Inagi R; Inoue K
    J Immunol; 1992 Feb; 148(3):827-36. PubMed ID: 1730875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
    Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.
    Goldman RC; Joiner K; Leive L
    J Bacteriol; 1984 Sep; 159(3):877-82. PubMed ID: 6207166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli.
    Taylor PW; Kroll HP
    Mol Immunol; 1984 Jul; 21(7):609-20. PubMed ID: 6379418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-induced blebbing and vesiculation of the outer membrane of Escherichia coli.
    Katsui N; Tsuchido T; Hiramatsu R; Fujikawa S; Takano M; Shibasaki I
    J Bacteriol; 1982 Sep; 151(3):1523-31. PubMed ID: 7050091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the phospholipids of Escherichia coli k12.
    Batley M; Packer NH; Redmond JW
    Biochim Biophys Acta; 1982 Mar; 710(3):400-5. PubMed ID: 6803841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli.
    Inoue K; Kinoshita T; Okada M; Akiyama Y
    J Immunol; 1977 Jul; 119(1):65-72. PubMed ID: 326965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
    Dankert JR
    J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.